Literature DB >> 30624551

Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder.

Gihyun Yoon1, Ismene L Petrakis1, John H Krystal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30624551      PMCID： PMC6439824          DOI： 10.1001/jamapsychiatry.2018.3990

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  5 in total

1.  Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.

Authors:  John H Krystal; Steven Madonick; Edward Perry; Ralitza Gueorguieva; Laura Brush; Yola Wray; Aysenil Belger; Deepak Cyril D'Souza
Journal:  Neuropsychopharmacology       Date:  2006-01-04       Impact factor: 7.853

2.  Is There Really Nothing New Under the Sun? Is Low-Dose Ketamine a Fast-Acting Antidepressant Simply Because It Is An Opioid?

Authors:  Mark S George
Journal:  Am J Psychiatry       Date:  2018-08-29       Impact factor: 18.112

3.  Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

Authors:  Nolan R Williams; Boris D Heifets; Christine Blasey; Keith Sudheimer; Jaspreet Pannu; Heather Pankow; Jessica Hawkins; Justin Birnbaum; David M Lyons; Carolyn I Rodriguez; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2018-08-29       Impact factor: 18.112

4.  Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.

Authors:  K Hirota; H Okawa; B L Appadu; D K Grandy; L A Devi; D G Lambert
Journal:  Anesthesiology       Date:  1999-01       Impact factor: 7.892

Review 5.  A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.

Authors:  Gerard Sanacora; Mark A Frye; William McDonald; Sanjay J Mathew; Mason S Turner; Alan F Schatzberg; Paul Summergrad; Charles B Nemeroff
Journal:  JAMA Psychiatry       Date:  2017-04-01       Impact factor: 21.596
  5 in total
  29 in total

Review 1.  Ketamine: Leading us into the future for development of antidepressants.

Authors:  Flavia R Carreno; Daniel J Lodge; Alan Frazer
Journal:  Behav Brain Res       Date:  2020-02-02       Impact factor: 3.332

Review 2.  Ketamine: The final frontier or another depressing end?

Authors:  Omar K Sial; Eric M Parise; Lyonna F Parise; Tamara Gnecco; Carlos A Bolaños-Guzmán
Journal:  Behav Brain Res       Date:  2020-02-01       Impact factor: 3.332

3.  Reply to Hashimoto: Ketamine is not an opioid but requires opioid system for antidepressant actions.

Authors:  Roberto Malinow; Matthew E Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-19       Impact factor: 11.205

4.  Are NMDA and opioid receptors involved in the antidepressant actions of ketamine?

Authors:  Kenji Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-19       Impact factor: 11.205

Review 5.  Rodent ketamine depression-related research: Finding patterns in a literature of variability.

Authors:  Andrew J Polis; Paul J Fitzgerald; Pho J Hale; Brendon O Watson
Journal:  Behav Brain Res       Date:  2019-08-13       Impact factor: 3.332

6.  Response to intravenous racemic ketamine after switch from intranasal (S)-ketamine on symptoms of treatment-resistant depression and post-traumatic stress disorder in Veterans: A retrospective case series.

Authors:  Sean Bentley; Hewa Artin; Eamonn Mehaffey; Fred Liu; Kevin Sojourner; Andrew Bismark; David Printz; Ellen E Lee; Brian Martis; Sharon De Peralta; Dewleen G Baker; Jyoti Mishra; Dhakshin Ramanathan
Journal:  Pharmacotherapy       Date:  2022-02-24       Impact factor: 4.705

Review 7.  Suicide Has Many Faces, So Does Ketamine: a Narrative Review on Ketamine's Antisuicidal Actions.

Authors:  Aiste Lengvenyte; Emilie Olié; Philippe Courtet
Journal:  Curr Psychiatry Rep       Date:  2019-12-03       Impact factor: 5.285

8.  Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents.

Authors:  Matthew E Klein; Joshua Chandra; Salma Sheriff; Roberto Malinow
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-15       Impact factor: 11.205

Review 9.  Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action.

Authors:  Madison N Irwin; Amy VandenBerg
Journal:  Ment Health Clin       Date:  2021-05-12

Review 10.  Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data.

Authors:  Andreas Bender; Isidro Cortes-Ciriano
Journal:  Drug Discov Today       Date:  2021-01-27       Impact factor: 7.851
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.